FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:241-250 July 20, 2006 Number 3 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by O'Rahilly, S. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Common polymorphisms of the transcription factor 7–like 2 gene (TCF7L2) have recently been associated with type 2 diabetes. We examined whether the two most strongly associated variants (rs12255372 and rs7903146) predict the progression to diabetes in persons with impaired glucose tolerance who were enrolled in the Diabetes Prevention Program, in which lifestyle intervention or treatment with metformin was compared with placebo.

Methods We genotyped these variants in 3548 participants and performed Cox regression analysis using genotype, intervention, and their interactions as predictors. We assessed the effect of genotype on measures of insulin secretion and insulin sensitivity at baseline and at one year.

Results Over an average period of three years, participants with the risk-conferring TT genotype at rs7903146 were more likely to have progression from impaired glucose tolerance to diabetes than were CC homozygotes (hazard ratio, 1.55; 95 percent confidence interval, 1.20 to 2.01; P<0.001). The effect of genotype was stronger in the placebo group (hazard ratio, 1.81; 95 percent confidence interval, 1.21 to 2.70; P=0.004) than in the metformin and lifestyle-intervention groups (hazard ratios, 1.62 and 1.15, respectively; P for the interaction between genotype and intervention not significant). The TT genotype was associated with decreased insulin secretion but not increased insulin resistance at baseline. Similar results were obtained for rs12255372.

Conclusions Common variants in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance. The risk-conferring genotypes in TCF7L2 are associated with impaired beta-cell function but not with insulin resistance. (ClinicalTrials.gov number, NCT00004992 [ClinicalTrials.gov] .)

Source Information

From the Diabetes Prevention Program Outcomes Study Coordinating Center, George Washington University, Rockville, Md.

Address reprint requests to Dr. Florez at the Diabetes Prevention Program Coordinating Center, the Biostatistics Center, George Washington University, 6110 Executive Blvd., Suite 750, Rockville, MD 20852, or at dppmail{at}biostat.bsc.gwu.edu.

Full Text of this Article

This article has been cited by other articles:

• Yi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., Jin, T. (2008). Cross Talk between the Insulin and Wnt Signaling Pathways: Evidence from Intestinal Endocrine L Cells. Endocrinology 149: 2341-2351 [Abstract] [Full Text]  
• Folsom, A. R., Pankow, J. S., Peacock, J. M., Bielinski, S. J., Heiss, G., Boerwinkle, E. (2008). Variation in TCF7L2 and Increased Risk of Colon Cancer: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 31: 905-909 [Abstract] [Full Text]  
• Cervin, C., Lyssenko, V., Bakhtadze, E., Lindholm, E., Nilsson, P., Tuomi, T., Cilio, C. M., Groop, L. (2008). Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes. Diabetes 57: 1433-1437 [Abstract] [Full Text]  
• Liu, Z., Habener, J. F. (2008). Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation. J. Biol. Chem. 283: 8723-8735 [Abstract] [Full Text]  
• Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., Maedler, K. (2008). Transcription Factor 7-Like 2 Regulates {beta}-Cell Survival and Function in Human Pancreatic Islets. Diabetes 57: 645-653 [Abstract] [Full Text]  
• Omori, S., Tanaka, Y., Takahashi, A., Hirose, H., Kashiwagi, A., Kaku, K., Kawamori, R., Nakamura, Y., Maeda, S. (2008). Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population. Diabetes 57: 791-795 [Abstract] [Full Text]  
• Iakoubova, O. A., Sabatine, M. S., Rowland, C. M., Tong, C. H., Catanese, J. J., Ranade, K., Simonsen, K. L., Kirchgessner, T. G., Cannon, C. P., Devlin, J. J., Braunwald, E. (2008). Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.. J Am Coll Cardiol 51: 449-455 [Abstract] [Full Text]  
• Palmer, N. D., Lehtinen, A. B., Langefeld, C. D., Campbell, J. K., Haffner, S. M., Norris, J. M., Bergman, R. N., Goodarzi, M. O., Rotter, J. I., Bowden, D. W. (2008). Association of TCF7L2 Gene Polymorphisms with Reduced Acute Insulin Response in Hispanic Americans. J. Clin. Endocrinol. Metab. 93: 304-309 [Abstract] [Full Text]  
• Kang, E. S., Kim, M. S., Kim, Y. S., Hur, K. Y., Han, S. J., Nam, C. M., Ahn, C. W., Cha, B. S., Kim, S. I., Lee, H. C. (2008). A Variant of the Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Posttransplantation Diabetes Mellitus in Renal Allograft Recipients. Diabetes Care 31: 63-68 [Abstract] [Full Text]  
• Vaxillaire, M., Veslot, J., Dina, C., Proenca, C., Cauchi, S., Charpentier, G., Tichet, J., Fumeron, F., Marre, M., Meyre, D., Balkau, B., Froguel, P., for the DESIR Study Group, (2008). Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study. Diabetes 57: 244-254 [Abstract] [Full Text]  
• Taylor, C. Y., Guillen, I. A., Nazabal, M., Fernandez, J. R., Silva, J. A. (2007). Electrophoretic Techniques Applied to the Detection and Analysis of the Human Microsatellite Dg10s478. J Biomol Tech 18: 298-305 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2007). Diabetes and Obesity: Part 1. Diabetes Care 30: 3145-3151 [Full Text]  
• Taylor, K. D., Norris, J. M., Rotter, J. I. (2007). Genome-Wide Association: Which Do You Want First: the Good News, the Bad News, or the Good News?. Diabetes 56: 2844-2848 [Full Text]  
• Hanson, R. L., Bogardus, C., Duggan, D., Kobes, S., Knowlton, M., Infante, A. M., Marovich, L., Benitez, D., Baier, L. J., Knowler, W. C. (2007). A Search for Variants Associated With Young-Onset Type 2 Diabetes in American Indians in a 100K Genotyping Array. Diabetes 56: 3045-3052 [Abstract] [Full Text]  
• Florez, J. C., Manning, A. K., Dupuis, J., McAteer, J., Irenze, K., Gianniny, L., Mirel, D. B., Fox, C. S., Cupples, L. A., Meigs, J. B. (2007). A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study: Replication and Integration With Other Genome-Wide Datasets. Diabetes 56: 3063-3074 [Abstract] [Full Text]  
• Guo, T., Hanson, R. L., Traurig, M., Li Muller, Y., Ma, L., Mack, J., Kobes, S., Knowler, W. C., Bogardus, C., Baier, L. J. (2007). TCF7L2 Is Not a Major Susceptibility Gene for Type 2 Diabetes in Pima Indians: Analysis of 3,501 Individuals. Diabetes 56: 3082-3088 [Abstract] [Full Text]  
• Dunnick, J. K., Thayer, K. A., Travlos, G. S. (2007). Inclusion of Biomarkers for Detecting Perturbations in the Heart and Lung and Lipid/Carbohydrate Metabolism in National Toxicology Program Studies. Toxicol Sci 100: 29-35 [Abstract] [Full Text]  
• Goodarzi, M. O., Rotter, J. I. (2007). Testing the Gene or Testing a Variant?: The Case of TCF7L2. Diabetes 56: 2417-2419 [Full Text]  
• Chang, Y.-C., Chang, T.-J., Jiang, Y.-D., Kuo, S.-S., Lee, K.-C., Chiu, K. C., Chuang, L.-M. (2007). Association Study of the Genetic Polymorphisms of the Transcription Factor 7-Like 2 (TCF7L2) Gene and Type 2 Diabetes in the Chinese Population. Diabetes 56: 2631-2637 [Abstract] [Full Text]  
• Sale, M. M., Smith, S. G., Mychaleckyj, J. C., Keene, K. L., Langefeld, C. D., Leak, T. S., Hicks, P. J., Bowden, D. W., Rich, S. S., Freedman, B. I. (2007). Variants of the Transcription Factor 7-Like 2 (TCF7L2) Gene Are Associated With Type 2 Diabetes in an African-American Population Enriched for Nephropathy. Diabetes 56: 2638-2642 [Abstract] [Full Text]  
• Ng, M. C. Y., Tam, C. H. T., Lam, V. K. L., So, W.-Y., Ma, R. C. W., Chan, J. C. N. (2007). Replication and Identification of Novel Variants at TCF7L2 Associated with Type 2 Diabetes in Hong Kong Chinese. J. Clin. Endocrinol. Metab. 92: 3733-3737 [Abstract] [Full Text]  
• Raitakari, O. T., Ronnemaa, T., Huupponen, R., Viikari, L., Fan, M., Marniemi, J., Hutri-Kahonen, N., Viikari, J. S.A., Lehtimakimd, T. (2007). Variation of the Transcription Factor 7-Like 2 (TCF7L2) Gene Predicts Impaired Fasting Glucose in Healthy Young Adults: The Cardiovascular Risk in Young Finns Study. Diabetes Care 30: 2299-2301 [Full Text]  
• Valdez, R., Greenlund, K. J., Khoury, M. J., Yoon, P. W. (2007). Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective. Pediatrics 120: S78-S86 [Abstract] [Full Text]  
• Pearson, E. R., Donnelly, L. A., Kimber, C., Whitley, A., Doney, A. S.F., McCarthy, M. I., Hattersley, A. T., Morris, A. D., Palmer, C. N.A. (2007). Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas: A GoDARTs Study. Diabetes 56: 2178-2182 [Abstract] [Full Text]  
• Loos, R. J.F., Franks, P. W., Francis, R. W., Barroso, I., Gribble, F. M., Savage, D. B., Ong, K. K., O'Rahilly, S., Wareham, N. J. (2007). TCF7L2 Polymorphisms Modulate Proinsulin Levels and {beta}-Cell Function in a British Europid Population. Diabetes 56: 1943-1947 [Abstract] [Full Text]  
• Duan, Q. L., Dube, M.-P., Frasure-Smith, N., Barhdadi, A., Lesperance, F., Theroux, P., St-Onge, J., Rouleau, G. A., McCaffery, J. M. (2007). Additive Effects of Obesity and TCF7L2 Variants on Risk for Type 2 Diabetes Among Cardiac Patients. Diabetes Care 30: 1621-1623 [Full Text]  
• Korner, A., Berndt, J., Stumvoll, M., Kiess, W., Kovacs, P. (2007). TCF7L2 Gene Polymorphisms Confer an Increased Risk for Early Impairment of Glucose Metabolism and Increased Height in Obese Children. J. Clin. Endocrinol. Metab. 92: 1956-1960 [Abstract] [Full Text]  
• Florez, J. C., Jablonski, K. A., Sun, M. W., Bayley, N., Kahn, S. E., Shamoon, H., Hamman, R. F., Knowler, W. C., Nathan, D. M., Altshuler, D., for the Diabetes Prevention Program Research Group, (2007). Effects of the Type 2 Diabetes-Associated PPARG P12A Polymorphism on Progression to Diabetes and Response to Troglitazone. J. Clin. Endocrinol. Metab. 92: 1502-1509 [Abstract] [Full Text]  
• Clee, S. M., Attie, A. D. (2007). The Genetic Landscape of Type 2 Diabetes in Mice. Endocr. Rev. 28: 48-83 [Abstract] [Full Text]  
• Lehman, D. M., Hunt, K. J., Leach, R. J., Hamlington, J., Arya, R., Abboud, H. E., Duggirala, R., Blangero, J., Goring, H. H.H., Stern, M. P. (2007). Haplotypes of Transcription Factor 7-Like 2 (TCF7L2) Gene and Its Upstream Region Are Associated With Type 2 Diabetes and Age of Onset in Mexican Americans. Diabetes 56: 389-393 [Abstract] [Full Text]  
• Schadt, E. E., Lum, P. Y. (2006). Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J. Lipid Res. 47: 2601-2613 [Abstract] [Full Text]  
• Florez, J. C., Saxena, R., Winckler, W., Burtt, N. P., Almgren, P., Bengtsson Bostrom, K., Tuomi, T., Gaudet, D., Ardlie, K. G., Daly, M. J., Altshuler, D., Hirschhorn, J. N., Groop, L. (2006). The Kruppel-Like Factor 11 (KLF11) Q62R Polymorphism Is Not Associated With Type 2 Diabetes in 8,676 People. Diabetes 55: 3620-3624 [Abstract] [Full Text]  
• (2006). Endocrinology & Metabolism News, September 2006. J. Clin. Endocrinol. Metab. 91: 17a-17a [Full Text]  
• O'Rahilly, S., Wareham, N. J. (2006). Genetic variants and common diseases--better late than never.. NEJM 355: 306-308 [Full Text]